MSF Advice: Kelley versus Owen for Life Sciences

Hey ya'll, I hope you guys are having a great weekend! I've been accepted into several MSF programs and wanted to get some outside opinions on the top 2 programs since I'm new to the world of finance.

I graduated back in 2024 with a life sciences STEM degree (3.85 GPA at an in-state non-target) and have been working as a clinical research associate at a hospital. I've been able to assist with a few strategy/operations projects here and there, but haven't been able to switch roles or jobs due to my lack of a technical degree/finance education. As a result, I've chosen to pursue a MSFinance degree since I've saved up a fair amount and have zero loans from undergrad.

I would love to break into a business development or VC-related role in the life sciences, biomedical, or pharma field after completing my program. The top two schools I've been accepted into are IU's 18-month MSF program and Vanderbilt's 10-month MSF program. Owen is ~$75,000 and Kelley is ~$56,000, including living expenses and accounting for scholarships.  

I was accepted into Kelley's program earlier, so I've been able to do a decent amount of networking and have gathered more info versus Owen, but I've outlined some of the outstanding details for each program:

Kelley: I was accepted into their CBLS graduate associate program, Kelley has a VC Fellowship program, Kelley is also very heavily involved with IU Labs (which has a close partnership with Plug and Play VC and Eli Lilly), and the 18-month format would allow for an extra semester of recruiting if I didn't get a return offer from a summer internship or allow me to defer classes so that I can potentially continue to work remotely (downside of the program is that I would not have access to the Kelley workshops)

Owen: Vanderbilt is a very well-known program and has very good outcomes (they are more focused on IB, but they have an IB and consulting "academy"). I've been told by multiple people that they have a stronger alumni network, the program also has a leadership development program, and Nashville is a hub for healthcare entrepreneurship.

I know the market is pretty tough/competitive right now, and maybe I'm forgetting additional details for each program. Nevertheless, I would highly appreciate getting everyone's insight on what may be the better fit for my long-term goals.  

Which School is a better fit?

Kelley
50% (2 votes)
Owen
50% (2 votes)
Total votes: 4
3 Comments
 

Based on the most helpful WSO content, here's a breakdown of your options and how they align with your goals:

Kelley MSF

  • Strengths for Life Sciences/VC: Kelley’s CBLS (Center for the Business of Life Sciences) graduate associate program and its partnership with IU Labs, Plug and Play VC, and Eli Lilly are significant advantages. These connections directly align with your interest in life sciences, biomedical, and pharma business development or VC roles.
  • VC Fellowship: The VC Fellowship program is a unique opportunity that could provide hands-on experience and networking in venture capital, which is a key area of interest for you.
  • 18-Month Format: The extended timeline allows for more flexibility, including an extra semester for recruiting or continuing remote work. This could be a safety net if you don’t secure a return offer from a summer internship.
  • Downside: Lack of access to Kelley workshops might limit some structured recruiting support, but the CBLS and VC Fellowship programs could compensate for this.

Owen MSF

  • Healthcare Entrepreneurship Hub: Nashville’s reputation as a healthcare entrepreneurship hub is a strong point, especially given your life sciences background. This could provide unique networking opportunities in the healthcare and biomedical sectors.
  • Alumni Network: Vanderbilt’s alumni network is often regarded as stronger, which could be beneficial for long-term career growth and job placement.
  • Leadership Development Program: This could help you build soft skills that are critical for business development and VC roles.
  • Focus on IB/Consulting: While Owen has strong outcomes, its focus on IB and consulting may not align as directly with your life sciences and VC aspirations.

Key Considerations

  1. Alignment with Goals: Kelley’s CBLS, VC Fellowship, and partnerships with life sciences-focused organizations like Eli Lilly seem to align more closely with your stated career goals in life sciences and VC.
  2. Flexibility: The 18-month format at Kelley provides more time for recruiting and internships, which could be crucial in a competitive job market.
  3. Cost: Kelley is ~$19,000 cheaper than Owen, which is a significant factor if you’re self-funding your education.

Recommendation

Given your specific goals in life sciences, biomedical, and pharma business development or VC, Kelley’s MSF program appears to be the better fit. The CBLS program, VC Fellowship, and partnerships with life sciences organizations provide a tailored pathway to your desired career. The additional semester for recruiting also adds flexibility, which could be invaluable in the current market.

However, if you value a stronger alumni network and the healthcare entrepreneurship ecosystem in Nashville, Owen could still be a solid choice. Ultimately, Kelley’s offerings seem more directly aligned with your aspirations.

Sources: MSF Class of 2019, MS Finance - University of Rochester, MSF Question and Answer, MSF Class of 2019, MSF or MBA for my experience level?

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Since the VC Fellowship isn't guaranteed, does this shift my decision at all against Kelley?

Also,  even though consulting isn't my primary goal, I would be more than happy to try and apply for consulting positions out of the MSF degree if it will allow me to ultimately get into a life science business development position or a position at a life science VC firm. 

 

Quaerat fugiat maiores esse blanditiis at. Provident dignissimos quia sed alias.

Libero odio voluptas omnis aut consequatur voluptatem enim. Nesciunt blanditiis sequi a reprehenderit. Ut impedit aut in reiciendis sit quisquam sit.

Perspiciatis voluptatum atque eum sit quisquam nostrum nobis. Laudantium incidunt quo necessitatibus. Vero pariatur aut omnis tenetur aut. Possimus consequatur recusandae veritatis repellendus numquam necessitatibus. Optio consequuntur sunt expedita modi.

Career Advancement Opportunities

June 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.8%
  • JPMorgan 01 98.2%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 01 98.8%
  • Evercore 01 98.2%
  • BMO Capital Markets 12 97.6%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

June 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 05 98.2%
  • JPMorgan No 97.7%
  • BMO Capital Markets 12 97.1%

Total Avg Compensation

June 2026 Investment Banking

  • Vice President (14) $434
  • Associates (43) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (75) $151
  • Intern/Summer Analyst (66) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
GameTheory's picture
GameTheory
98.9
8
CompBanker's picture
CompBanker
98.9
9
DrApeman's picture
DrApeman
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”